Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. The Dow Jones Industrial Average ( ^DJI) is trading up 45 points (+0.3%) at 14,016 as of Tuesday, Feb 12, 2013, 12:35 p.m. ET. During this time, 265.1 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 626.4 million. The NYSE advances/declines ratio sits at 1,810 issues advancing vs. 1,069 declining with 160 unchanged.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Holding back the Dow today is Cisco Systems (Nasdaq: CSCO), which is lagging the broader Dow index with a 23-cent decline (-1.1%) bringing the stock to $21.04. Volume for Cisco Systems currently sits at 26.3 million shares traded vs. an average daily trading volume of 38.6 million shares. Cisco Systems has a market cap of $112.34 billion and is part of the technology sector and computer hardware industry. Shares are up 7.7% year to date as of Monday's close. The stock's dividend yield sits at 2.6%. Cisco Systems, Inc. designs, manufactures, and sells Internet protocol (IP) based networking and other products related to the communications and information technology industries worldwide. The company has a P/E ratio of 13.7, below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Cisco Systems as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.